PMC:7346000 / 0-853
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2 | 0-8 | Disease | denotes | COVID-19 | MESH:C000657245 |
3 | 20-43 | Disease | denotes | Pulmonary Aspergillosis | MESH:D055732 |
25 | 256-264 | Species | denotes | patients | Tax:9606 |
28 | 102-111 | Species | denotes | influenza | Tax:11309 |
33 | 113-135 | Disease | denotes | coronavirus disease-19 | MESH:C000657245 |
34 | 137-145 | Disease | denotes | COVID-19 | MESH:C000657245 |
35 | 160-195 | Disease | denotes | acute respiratory distress syndrome | MESH:D012128 |
36 | 197-201 | Disease | denotes | ARDS | MESH:D012128 |
37 | 278-301 | Disease | denotes | pulmonary aspergillosis | MESH:D055732 |
38 | 320-328 | Disease | denotes | COVID-19 | MESH:C000657245 |
39 | 340-363 | Disease | denotes | pulmonary aspergillosis | MESH:D055732 |
40 | 464-472 | Disease | denotes | COVID-19 | MESH:C000657245 |
41 | 489-541 | Disease | denotes | pulmonary epithelial damage and inflammatory disease | MESH:D008171 |
42 | 583-606 | Disease | denotes | pulmonary aspergillosis | MESH:D055732 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 0-8 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 30-43 | Disease | denotes | Aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
T3 | 45-49 | Disease | denotes | CAPA | http://purl.obolibrary.org/obo/MONDO_0007163 |
T4 | 102-111 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
T5 | 137-145 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 160-195 | Disease | denotes | acute respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0006502 |
T7 | 166-195 | Disease | denotes | respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0009971 |
T8 | 197-201 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
T9 | 288-301 | Disease | denotes | aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
T10 | 320-328 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T11 | 350-363 | Disease | denotes | aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
T12 | 365-369 | Disease | denotes | CAPA | http://purl.obolibrary.org/obo/MONDO_0007163 |
T13 | 464-472 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T14 | 521-541 | Disease | denotes | inflammatory disease | http://purl.obolibrary.org/obo/MONDO_0021166 |
T15 | 593-606 | Disease | denotes | aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
T16 | 841-845 | Disease | denotes | CAPA | http://purl.obolibrary.org/obo/MONDO_0007163 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 203-206 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T2 | 308-310 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
T3 | 499-509 | http://purl.obolibrary.org/obo/CL_0000066 | denotes | epithelial |
T4 | 683-693 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T5 | 750-751 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 697-706 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 814-826 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | pathogenesis |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 166-186 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-79 | Sentence | denotes | COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment |
T2 | 81-89 | Sentence | denotes | Abstract |
T3 | 90-397 | Sentence | denotes | Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until June 2020. |
T4 | 398-607 | Sentence | denotes | The release of danger-associated molecular patterns during severe COVID-19 results in both pulmonary epithelial damage and inflammatory disease, which are predisposing risk factors for pulmonary aspergillosis. |
T5 | 608-827 | Sentence | denotes | Moreover, collateral effects of host recognition pathways required for the activation of antiviral immunity may, paradoxically, contribute to a highly permissive inflammatory environment that favors fungal pathogenesis. |